Compositions and Methods for Screening Mutations in Thyroid Cancer

The USPTO published a biotechnology patent application disclosing methods for determining whether thyroid nodule patients with indeterminate cytology will benefit from diagnostic surgery, such as lobectomy. The methods involve screening thyroid nodules and detecting alterations in target nucleic acid sequences corresponding to thyroid cancer-related genes. Kits for practicing the methods are also disclosed.

Affected parties in the biotechnology, pharmaceutical, and medical device sectors should monitor this application for potential implications on diagnostic testing for thyroid cancer. If granted, the patent may affect development and commercialization of molecular diagnostic tests for thyroid nodule evaluation. Healthcare providers offering thyroid cancer screening should be aware of potential licensing requirements.